Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T19:02:44.813Z.
Calculation as of: 2026-10-06T19:02:44.813Z.
Quote observation: 2026-10-06T18:38:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 05f4ae4a030aaca39f2691a5695262832c6d48704f11c5316ed8238ac0b3761e
EARNINGS YIELD
N/A
Market Cap
$352721.00
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$484571.00
Earnings Yield
N/A
TTM Avg
79.57%
3Y Avg
139.63%
5Y Avg
139.63%
Market Cap
$109777.00
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Niki BioSolutions, Inc. (NIKI) | $381940.00 | N/A | N/A | N/A | N/A |
| Virax Biolabs Group Limited (VRAX)vs › | $352721.00 | N/A | N/A | N/A | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $484571.00 | N/A | 79.57% | 139.63% | 139.63% |
| SciSparc Ltd. (SPRC)vs › | $242924.00 | N/A | N/A | N/A | N/A |
| VivoSim Labs, Inc. (VIVS)vs › | $530421.00 | N/A | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB)vs › | $563178.00 | N/A | N/A | N/A | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109777.00 | N/A | N/A | N/A | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $96088.00 | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $674464.00 | N/A | N/A | N/A | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $72479.00 | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute